FOR IMMEDIATE RELEASE  October 13, 2023  Ponte Vedra, FL – HEMOTAG, a non-invasive and portable structural heart health monitoring device, took the first place on the Bio Pitch during the 2023 BioFlorida Conference on October 13, 2023. Out of an impressive 66 companies who applied for the competition, 16 companies were selected to participate in …

Aventusoft/HEMOTAG Takes First Place in the Bio Pitch During BioFlorida 2023  Read More »

PRESS RELEASE FOR IMMEDIATE RELEASE [Boca Raton, FL, September 14, 2023] – Aventusoft, a pioneering research-driven company dedicated to developing innovative products that address heart conditions by challenging established paradigms, is thrilled to announce its selection to one of the National Institutes of Health (NIH) showcase companies to attend the annual HLTH Conference from October …

Aventusoft to Launch HEMOTAG® Vitals at the Prestigious HLTH Conference 2023, Following Selection by NIH  Read More »